Bumper Offer - Urjas oil Just @ Rs. 1
Nebisartan is an allopathic medicine The correct dosage of Nebisartan depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Nebisartan is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Nebisartan is used -
Severe
Moderate
Mild
Common
Is the use of Nebisartan safe for pregnant women?
Nebisartan shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebisartan safe during breastfeeding?
Nebisartan should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Nebisartan on the Kidneys?
Nebisartan rarely affects the kidneys.
What is the effect of Nebisartan on the Liver?
Nebisartan is rarely harmful for the liver.
What is the effect of Nebisartan on the Heart?
Very few cases of side effects of Nebisartan on the heart have been reported.
Nebisartan should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nebisartan unless your doctor advises you to do so -
Is this Nebisartan habit forming or addictive?
Forming a habit of Nebisartan has not been reported.
Interaction between Food and Nebisartan
When consumed with certain foods, Nebisartan may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Nebisartan
Taking Nebisartan with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
